Process Control Template

---
title: "Process Control Template"
methodology: "universal"
complexity: "advanced"
owner: "mirichard"
updated: "2026-09-19"
primary_principles: ["quality-by-design", "evidence-based-decisions"]
secondary_principles: ["risk-optimization"]
principle_rationale: "Links critical process attributes and parameters to statistical monitoring, justified limits and documented responses to adverse trends."
---

# Process Control Template

## When to Use

- When a manufacturing process needs defined monitoring and response controls.
- When qualified owners must connect critical attributes, parameters, trends, and deviations.

## When NOT to Use

- To adopt example control limits without process-specific justification.
- Do not report sample values, unsupported ratings, or missing data as verified performance. See [Metric without source](../../../../../docs/principles/anti-patterns.md#metric-source).

## Pairs Well With

- [Pharmaceutical Qbd Template](../../../../../domains/delivery/industry-specializations/healthcare-pharmaceutical/lifecycle/pharmaceutical_qbd_template.md).
- [Process Validation Protocol Template](../../../../../domains/delivery/industry-specializations/healthcare-pharmaceutical/regulatory/process_validation_protocol_template.md).

Selection context: Delivery domain; universal methodology; advanced complexity. Match the situations above to project phase, risk, team size, and industry using the [decision-engine context model](../../../../../meta/architecture-research/800-801-context-assessment-model.md).

## Applying this template

Treat filled examples, dates, numerical limits, sampling frequencies, and approval outcomes as illustrations. Before execution, replace them with the approved product/site requirements, scientific rationale, method references, responsible reviewer, and acceptance evidence. Record the applicable jurisdiction and current guidance edition; a completed worksheet alone does not demonstrate regulatory compliance.

| Requirement or limit | Applicable source / edition | Product-specific rationale | Approval / date | Execution evidence |
|---|---|---|---|---|
| [Requirement] | [Source] | [Rationale] | [Reviewer / date] | [Record] |


## Document Control

**Document ID:** [PC-XXX]\
**Version:** [1.0]  
**Effective Date:** [YYYY-MM-DD]  
**Review Date:** [YYYY-MM-DD]  
**Supersedes:** [Previous version, if applicable]  
**Product/Process:** [Product Name/Process Type]  
**Classification:** [e.g., Sterile/Non-sterile, Critical/Non-critical]  
**Last Updated:** [YYYY-MM-DD]

### Document History

| Version | Date | Description of Change | Author | Approved By |
|---------|------|------------------------|--------|------------|
| 1.0 | YYYY-MM-DD | Initial release | [Name] | [Name] |

### Distribution List

| Name | Department/Role | Date Distributed |
|------|----------------|------------------|
| [Name] | [Department/Role] | [YYYY-MM-DD] |
| [Name] | [Department/Role] | [YYYY-MM-DD] |

### Retention Period

This document must be retained for a minimum of [X] years after the expiry date of the relevant product or as required by applicable regulations, whichever is longer.

---

## 1. Introduction and Purpose

### 1.1 Purpose

This document defines the process control strategy for [Product/Process Name]. It establishes the framework for monitoring and controlling process parameters, identifying critical quality attributes, implementing statistical process control methods, and ensuring consistent product quality through systematic data evaluation.

### 1.2 Scope

This process control template applies to the [manufacturing/production/processing] of [Product Name] at [Facility Name]. It covers all stages of the manufacturing process from [starting point, e.g., raw material dispensing] to [endpoint, e.g., final packaging].

### 1.3 Regulatory Basis

This process control strategy has been developed in accordance with:
- FDA cGMP regulations (21 CFR Parts 210 and 211)
- EU GMP Guidelines (EudraLex Volume 4)
- ICH Q8 (Pharmaceutical Development)
- ICH Q9 (Quality Risk Management)
- ICH Q10 (Pharmaceutical Quality System)
- ICH Q11 (Development and Manufacture of Drug Substances)
- ICH Q12 (Lifecycle Management)
- [Other applicable regulations/guidelines]

---

## 2. Process Control Strategy Overview

### 2.1 Manufacturing Process Flow Diagram

[Insert process flow diagram showing all major unit operations, inputs, outputs, and control points]

### 2.2 Process Control Philosophy

The process control strategy for [Product/Process Name] is based on the following principles:
- Quality by design (QbD) approach to process understanding and control
- Risk-based control of critical process parameters (CPPs) that affect critical quality attributes (CQAs)
- Continuous monitoring and trending of process performance
- Statistical process control methods to detect process shifts and variability
- Preventive and corrective actions based on data-driven decisions
- Lifecycle approach to process validation and continuous improvement

### 2.3 Control Strategy Matrix

| Process Step | Input Material Controls | Process Controls | Output Controls | In-Process Controls | Release Controls |
|--------------|--------------------------|-----------------|-----------------|---------------------|------------------|
| [Process Step 1] | [e.g., Material specifications, testing] | [e.g., CPP monitoring] | [e.g., IPC testing] | [e.g., Sampling plan] | [e.g., Final testing] |
| [Process Step 2] | [e.g., Material specifications, testing] | [e.g., CPP monitoring] | [e.g., IPC testing] | [e.g., Sampling plan] | [e.g., Final testing] |
| [Process Step 3] | [e.g., Material specifications, testing] | [e.g., CPP monitoring] | [e.g., IPC testing] | [e.g., Sampling plan] | [e.g., Final testing] |

---

## 3. Critical Quality Attributes and Process Parameters

### 3.1 Critical Quality Attributes (CQAs)

| CQA | Target | Acceptance Criteria | Justification | Testing Method | Testing Frequency | Link to Patient Safety/Efficacy |
|-----|--------|---------------------|---------------|----------------|-------------------|--------------------------------|
| [CQA 1, e.g., Assay] | [e.g., 100%] | [e.g., 95.0-105.0%] | [Rationale for criticality] | [Test method] | [When tested] | [Impact on safety/efficacy] |
| [CQA 2, e.g., Dissolution] | [e.g., >80% in 30 min] | [e.g., NLT 80% (Q) in 30 min] | [Rationale for criticality] | [Test method] | [When tested] | [Impact on safety/efficacy] |
| [CQA 3, e.g., Impurity] | [e.g., <0.1%] | [e.g., NMT 0.2%] | [Rationale for criticality] | [Test method] | [When tested] | [Impact on safety/efficacy] |

### 3.2 Critical Process Parameters (CPPs)

| Process Step | CPP | Target | Operating Range | Proven Acceptable Range (PAR) | Impact on CQA | Control Method | Monitoring Frequency |
|--------------|-----|--------|-----------------|-------------------------------|--------------|----------------|---------------------|
| [Process Step 1] | [CPP 1, e.g., Mixing speed] | [e.g., 20 RPM] | [e.g., 18-22 RPM] | [e.g., 15-25 RPM] | [Affected CQA(s)] | [e.g., Automated control] | [e.g., Continuous] |
| [Process Step 2] | [CPP 2, e.g., Temperature] | [e.g., 60°C] | [e.g., 58-62°C] | [e.g., 55-65°C] | [Affected CQA(s)] | [e.g., Automated control] | [e.g., Continuous] |
| [Process Step 3] | [CPP 3, e.g., Compression force] | [e.g., 15 kN] | [e.g., 14-16 kN] | [e.g., 12-18 kN] | [Affected CQA(s)] | [e.g., Automated control] | [e.g., Continuous] |

### 3.3 Key Process Parameters (KPPs)

| Process Step | KPP | Target | Operating Range | Impact on Process | Control Method | Monitoring Frequency |
|--------------|-----|--------|-----------------|-------------------|----------------|---------------------|
| [Process Step 1] | [KPP 1, e.g., Mixing time] | [e.g., 15 min] | [e.g., 13-17 min] | [Effect on process] | [e.g., Timer] | [e.g., Each batch] |
| [Process Step 2] | [KPP 2, e.g., Fill volume] | [e.g., 100 mL] | [e.g., 98-102 mL] | [Effect on process] | [e.g., Weight check] | [e.g., Every 30 min] |

### 3.4 Parameter Classification Methodology

The classification of process parameters as critical (CPP), key (KPP), or non-critical is based on the following risk assessment methodology:
- **Critical Process Parameter (CPP)**: Parameter whose variability has a direct impact on a CQA and therefore should be monitored or controlled to ensure the process produces the desired quality.
- **Key Process Parameter (KPP)**: Parameter whose variability has an impact on a critical process attribute but not directly on a CQA.
- **Non-critical Process Parameter**: Parameter whose variability has no significant impact on CQAs or critical process attributes.

[Include details on how parameters were classified, risk assessment tools used, etc.]

---

## 4. Control Charts and Statistical Monitoring

### 4.1 Control Chart Selection

| Parameter/Attribute | Chart Type | Rational for Selection | Sample Size | Sampling Frequency | Responsible Person |
|---------------------|------------|------------------------|-------------|-------------------|-------------------|
| [Parameter 1] | [e.g., X-bar & R chart] | [Reason for choosing this chart type] | [e.g., n=5] | [e.g., Every 2 hours] | [Role] |
| [Parameter 2] | [e.g., Individual & MR chart] | [Reason for choosing this chart type] | [e.g., n=1] | [e.g., Each batch] | [Role] |
| [Parameter 3] | [e.g., p chart] | [Reason for choosing this chart type] | [e.g., n=100] | [e.g., Each shift] | [Role] |

### 4.2 Control Limit Establishment

| Parameter/Attribute | Control Chart | Method for Setting Limits | Review Frequency | Limit Adjustment Criteria |
|---------------------|---------------|---------------------------|------------------|---------------------------|
| [Parameter 1] | [Chart type] | [e.g., 20 batches historical data, 3-sigma limits] | [e.g., Quarterly] | [e.g., After process changes, trend observed] |
| [Parameter 2] | [Chart type] | [e.g., 30 batches historical data, 3-sigma limits] | [e.g., Quarterly] | [e.g., After process changes, trend observed] |
| [Parameter 3] | [Chart type] | [e.g., Process capability study, 3-sigma limits] | [e.g., Quarterly] | [e.g., After process changes, trend observed] |

### 4.3 Statistical Rules for Process Monitoring

The following statistical rules will be applied to detect special cause variation:

1. **Western Electric Rules (WER)/Nelson Rules:**
   - One point beyond Zone A (±3 standard deviations from center line)
   - Two out of three consecutive points in Zone A or beyond (same side)
   - Four out of five consecutive points in Zone B or beyond (same side)
   - Eight consecutive points on same side of center line
   - Six consecutive points steadily increasing or decreasing
   - Fifteen consecutive points in Zone C (both above and below center line)
   - Fourteen consecutive points alternating up and down
   - Eight consecutive points on both sides of center line with none in Zone C

2. **Additional Process-Specific Rules:**
   - [Any additional rules specific to this process]

### 4.4 Control Chart Templates

[Insert templates for each control chart type to be used, including blank charts that can be printed and filled out, or reference to electronic system]

---

## 5. Process Capability Assessment

### 5.1 Process Capability Indices

| CQA/CPP | Specification Limits | Capability Index | Target Value | Acceptance Criteria | Assessment Frequency |
|---------|---------------------|------------------|--------------|---------------------|----------------------|
| [CQA/CPP 1] | [e.g., LSL=95.0%, USL=105.0%] | Cp/Cpk | [e.g., Cpk ≥ 1.33] | [e.g., Cpk ≥ 1.33] | [e.g., After validation, annually] |
| [CQA/CPP 2] | [e.g., LSL=45, USL=55] | Pp/Ppk | [e.g., Ppk ≥ 1.33] | [e.g., Ppk ≥ 1.33] | [e.g., After validation, annually] |

### 5.2 Process Capability Calculation Methodology

Process capability will be calculated using the following methods:
- **Cp = (USL - LSL) / (6σ)** - Measures the potential capability based on process variability relative to specification width
- **Cpk = min[(USL - μ) / (3σ), (μ - LSL) / (3σ)]** - Measures the actual process capability, accounting for process centering
- **Pp = (USL - LSL) / (6s)** - Overall process performance index using sample standard deviation
- **Ppk = min[(USL - x̄) / (3s), (x̄ - LSL) / (3s)]** - Overall performance index, accounting for process centering

Where:
- USL = Upper Specification Limit
- LSL = Lower Specification Limit
- μ = Process mean (estimated by x̄)
- σ = Process standard deviation (estimated by s/c4 for short-term capability)
- s = Sample standard deviation (for long-term performance)
- x̄ = Sample mean

### 5.3 Process Capability Acceptance Criteria

- **Cpk/Ppk < 1.0**: Process is not capable of meeting specifications; immediate corrective action required
- **1.0 ≤ Cpk/Ppk < 1.33**: Process marginally capable; improvement plan required
- **1.33 ≤ Cpk/Ppk < 1.67**: Process is capable; routine monitoring required
- **Cpk/Ppk ≥ 1.67**: Process is highly capable; reduced monitoring may be considered

### 5.4 Process Capability Improvement Plan

| CQA/CPP | Current Capability | Target Capability | Improvement Strategy | Timeline | Responsible Person |
|---------|-------------------|-------------------|----------------------|----------|-------------------|
| [CQA/CPP 1] | [e.g., Cpk = 1.1] | [e.g., Cpk ≥ 1.33] | [e.g., Reduce variability by equipment upgrade] | [Timeline] | [Role] |
| [CQA/CPP 2] | [e.g., Cpk = 0.9] | [e.g., Cpk ≥ 1.33] | [e.g., Process optimization study] | [Timeline] | [Role] |

---

## 6. Alert and Action Limits

### 6.1 Alert and Action Limit Definition

- **Alert Limit**: A limit which, when exceeded, signals a potential trend or shift in the process that may require increased monitoring or investigation but does not require immediate process intervention.
- **Action Limit**: A limit which, when exceeded, requires immediate investigation and potentially corrective action to prevent the process from producing material that does not meet specifications.

### 6.2 Alert and Action Limits for Critical Parameters

| Parameter | Target | Alert Limits | Action Limits | Response to Alert | Response to Action Limit Excursion |
|-----------|--------|--------------|---------------|-------------------|-----------------------------------|
| [Parameter 1] | [Target] | [e.g., Target ± 2σ] | [e.g., Target ± 3σ or Specification limits] | [e.g., Increase monitoring frequency, notify supervisor] | [e.g., Stop process, investigate, implement CAPA] |
| [Parameter 2] | [Target] | [e.g., Target ± 2σ] | [e.g., Target ± 3σ or Specification limits] | [e.g., Increase monitoring frequency, notify supervisor] | [e.g., Stop process, investigate, implement CAPA] |
| [Parameter 3] | [Target] | [e.g., Target ± 2σ] | [e.g., Target ± 3σ or Specification limits] | [e.g., Increase monitoring frequency, notify supervisor] | [e.g., Stop process, investigate, implement CAPA] |

### 6.3 Method for Establishing Alert and Action Limits

| Limit Type | Methodology | Data Requirements | Review Frequency | Adjustment Criteria |
|------------|-------------|-------------------|------------------|---------------------|
| Statistical-based | [e.g., Based on 3-sigma limits from control charts] | [e.g., Minimum 30 data points from stable process] | [e.g., Annual or after process changes] | [e.g., After validated process changes] |
| Specification-based | [e.g., Derived from product specifications and safety margins] | [e.g., Validation data, stability data] | [e.g., When specifications change] | [e.g., After specification changes] |
| Experience-based | [e.g., Based on historical process knowledge] | [e.g., Process history, investigation reports] | [e.g., With annual product review] | [e.g., Based on new process understanding] |

### 6.4 Alert and Action Response Plan

| Scenario | Initial Response | Investigation Requirements | Documentation | Communication Plan | CAPA Requirements |
|----------|------------------|----------------------------|---------------|-------------------|-------------------|
| Alert Limit Exceeded | [Immediate actions] | [Investigation scope] | [Documentation requirements] | [Who to notify and when] | [CAPA requirements] |
| Action Limit Exceeded | [Immediate actions] | [Investigation scope] | [Documentation requirements] | [Who to notify and when] | [CAPA requirements] |
| Trending Toward Limits | [Immediate actions] | [Investigation scope] | [Documentation requirements] | [Who to notify and when] | [CAPA requirements] |
| Statistical Rule Violation | [Immediate actions] | [Investigation scope] | [Documentation requirements] | [Who to notify and when] | [CAPA requirements] |

---

## 7. Real-Time Release Testing (RTRT) Criteria

### 7.1 RTRT Strategy

[This section outlines the approach to real-time release testing, if applicable. If RTRT is not implemented, indicate future plans or state why it's not applicable.]

Real-time release testing for [Product Name] is based on:
- Validated predictive models of critical quality attributes
- In-line/at-line/on-line measurements of critical process parameters and material attributes
- Demonstrated process understanding and control
- Correlation between process parameters, material attributes, and final product quality

### 7.2 RTRT Parameters and Measurements

| CQA | Traditional Test Method | RTRT Approach | Process Analytical Technology | Measurement Location | Measurement Frequency | Correlation to CQA | Acceptance Criteria |
|-----|------------------------|---------------|-------------------------------|----------------------|----------------------|-------------------|---------------------|
| [CQA 1] | [Lab test method] | [e.g., NIR spectroscopy] | [PAT tool details] | [e.g., After blending] | [e.g., Continuous] | [Correlation data] | [Acceptance criteria] |
| [CQA 2] | [Lab test method] | [e.g., Raman spectroscopy] | [PAT tool details] | [e.g., During compression] | [e.g., Every tablet] | [Correlation data] | [Acceptance criteria] |

### 7.3 RTRT Validation Summary

| RTRT Method | Validation Protocol | Validation Report | Acceptance Criteria | Regulatory Status | Revalidation Frequency |
|-------------|---------------------|-------------------|---------------------|-------------------|------------------------|
| [Method 1] | [Protocol ID] | [Report ID] | [Summary of criteria] | [e.g., Approved by FDA] | [e.g., Annual] |
| [Method 2] | [Protocol ID] | [Report ID] | [Summary of criteria] | [e.g., Approved by FDA] | [e.g., Annual] |

### 7.4 RTRT Contingency Plan

| Scenario | Impact Assessment | Contingency Action | Notification Requirements | Documentation | Return to RTRT Criteria |
|----------|-------------------|-------------------|---------------------------|--------------|-------------------------|
| PAT system failure | [Impact on product release] | [e.g., Switch to traditional testing] | [Who to notify] | [Documentation required] | [Criteria to resume RTRT] |
| Calibration failure | [Impact on product release] | [e.g., Use backup system] | [Who to notify] | [Documentation required] | [Criteria to resume RTRT] |
| Model performance degradation | [Impact on product release] | [e.g., Model update] | [Who to notify] | [Documentation required] | [Criteria to resume RTRT] |

---

## 8. Process Analytical Technology (PAT) Implementation

### 8.1 PAT Tools and Applications

| Process Step | PAT Tool | Technology | Measurement | Implementation Status | Validation Status | Usage |
|--------------|----------|------------|-------------|----------------------|-------------------|-------|
| [Process Step 1] | [e.g., NIR analyzer] | [e.g., Near-infrared spectroscopy] | [e.g., Content uniformity] | [e.g., Implemented, In development] | [e.g., Validated, In validation] | [e.g., Monitoring, Control, RTRT] |
| [Process Step 2] | [e.g., Raman probe] | [e.g., Raman spectroscopy] | [e.g., Polymorph detection] | [e.g., Implemented, In development] | [e.g., Validated, In validation] | [e.g., Monitoring, Control, RTRT] |
| [Process Step 3] | [e.g., Vision system] | [e.g., Machine vision] | [e.g., Coating integrity] | [e.g., Implemented, In development] | [e.g., Validated, In validation] | [e.g., Monitoring, Control, RTRT] |

### 8.2 PAT Data Management

| Data Source | Data Collection Method | Data Storage | Data Backup | Data Integrity Controls | Retention Period |
|-------------|------------------------|--------------|-------------|-------------------------|------------------|
| [PAT Tool 1] | [e.g., Automated data acquisition] | [e.g., Secure database] | [e.g., Daily backup] | [e.g., Audit trail, access controls] | [e.g., 7 years] |
| [PAT Tool 2] | [e.g., Automated data acquisition] | [e.g., Secure database] | [e.g., Daily backup] | [e.g., Audit trail, access controls] | [e.g., 7 years] |

### 8.3 PAT Method Lifecycle Management

| PAT Method | Calibration Frequency | Maintenance Schedule | Performance Verification | Model Update Criteria | Responsible Person |
|------------|----------------------|---------------------|--------------------------|----------------------|-------------------|
| [Method 1] | [e.g., Daily, Weekly] | [e.g., Monthly, Quarterly] | [e.g., Standard sample test] | [e.g., When RMSEP > threshold] | [Role] |
| [Method 2] | [e.g., Daily, Weekly] | [e.g., Monthly, Quarterly] | [e.g., Standard sample test] | [e.g., When RMSEP > threshold] | [Role] |

### 8.4 PAT Implementation Roadmap

| Phase | PAT Tool | Implementation Timeline | Milestones | Success Criteria | Status |
|-------|----------|-------------------------|------------|------------------|--------|
| Phase 1 | [PAT Tool 1] | [Timeline] | [Key milestones] | [Criteria] | [Status] |
| Phase 2 | [PAT Tool 2] | [Timeline] | [Key milestones] | [Criteria] | [Status] |
| Phase 3 | [PAT Tool 3] | [Timeline] | [Key milestones] | [Criteria] | [Status] |

---

## 9. Data Review and Trending

### 9.1 Routine Data Review Schedule

| Data Type | Review Frequency | Responsible Person | Review Method | Documentation |
|-----------|------------------|-------------------|---------------|---------------|
| In-process control data | [e.g., Each batch] | [Role] | [e.g., Review against limits, trend analysis] | [e.g., Batch record, review form] |
| Control chart data | [e.g., Weekly] | [Role] | [e.g., Statistical analysis, pattern detection] | [e.g., Weekly report] |
| Process capability data | [e.g., Quarterly] | [Role] | [e.g., Capability analysis] | [e.g., Quarterly report] |
| PAT data | [e.g., Each batch] | [Role] | [e.g., Model performance review] | [e.g., PAT data review form] |

### 9.2 Periodic Trend Analysis

| Analysis Type | Frequency | Data Included | Analysis Method | Reporting Format | Recipients |
|---------------|-----------|--------------|-----------------|------------------|-----------|
| Short-term trends | [e.g., Weekly] | [e.g., Last 7 days of production] | [e.g., Time series analysis] | [e.g., Weekly trend report] | [Roles] |
| Long-term trends | [e.g., Monthly] | [e.g., Last 30 batches] | [e.g., Statistical trend analysis] | [e.g., Monthly trend report] | [Roles] |
| Annual product review | [e.g., Annual] | [e.g., All batches for the year] | [e.g., Comprehensive statistical analysis] | [e.g., APR report] | [Roles] |

### 9.3 Trend Analysis Methods

The following methods will be used for trend analysis:
- **Control chart pattern analysis** - detection of trends, shifts, and cycles
- **Linear regression analysis** - detection of upward or downward trends over time
- **CUSUM (Cumulative Sum) analysis** - detection of small persistent shifts in the process mean
- **EWMA (Exponentially Weighted Moving Average)** - detection of small shifts with reduced false alarms
- **Process capability trend analysis** - tracking of Cpk/Ppk values over time
- **Multivariate analysis** - for processes with multiple correlated variables
- [Other specific methods as applicable to the process]

### 9.4 Trend Reporting Template

[Insert template for trend reports or reference to electronic template]

### 9.5 Data-Driven Decision Making

| Trend Pattern | Interpretation | Required Action | Decision Authority | Documentation |
|---------------|----------------|-----------------|-------------------|---------------|
| Sustained upward/downward trend | [Interpretation] | [Required actions] | [Role] | [Documentation required] |
| Cyclical pattern | [Interpretation] | [Required actions] | [Role] | [Documentation required] |
| Step change | [Interpretation] | [Required actions] | [Role] | [Documentation required] |
| Increased variability | [Interpretation] | [Required actions] | [Role] | [Documentation required] |
| Decreased capability | [Interpretation] | [Required actions] | [Role] | [Documentation required] |

---

## 10. Continuous Process Verification

### 10.1 Continuous Process Verification Strategy

This section outlines the approach to ongoing process verification activities that provide documented evidence that the process remains in a state of control during commercial manufacturing.

The continuous process verification strategy includes:
- Routine collection and evaluation of process data
- Statistical process control and trend analysis
- Periodic evaluation of process capability
- Annual product quality review
- Management review of process performance
- Continuous improvement initiatives

### 10.2 Continuous Process Verification Parameters

| Parameter | Monitoring Frequency | Acceptance Criteria | Review Frequency | Responsible Person |
|-----------|---------------------|---------------------|------------------|-------------------|
| [Parameter 1] | [Frequency] | [Criteria] | [Review frequency] | [Role] |
| [Parameter 2] | [Frequency] | [Criteria] | [Review frequency] | [Role] |
| [Parameter 3] | [Frequency] | [Criteria] | [Review frequency] | [Role] |

### 10.3 Continuous Process Verification Reporting

| Report Type | Frequency | Content | Recipients | Follow-up Actions |
|-------------|-----------|---------|------------|-------------------|
| CPV Summary Report | [e.g., Quarterly] | [Report content] | [Roles] | [Follow-up process] |
| Annual Product Review | [Annual] | [Report content] | [Roles] | [Follow-up process] |
| Management Review | [e.g., Semi-annual] | [Report content] | [Roles] | [Follow-up process] |

### 10.4 Continuous Improvement Process

| Stage | Activities | Frequency | Responsible Person | Documentation |
|-------|------------|-----------|-------------------|---------------|
| Identify Improvement Opportunities | [Activities] | [Frequency] | [Role] | [Documentation] |
| Evaluate and Prioritize | [Activities] | [Frequency] | [Role] | [Documentation] |
| Implement Improvements | [Activities] | [As needed] | [Role] | [Documentation] |
| Verify Effectiveness | [Activities] | [After implementation] | [Role] | [Documentation] |
| Standardize | [Activities] | [After verification] | [Role] | [Documentation] |

---

## 11. Process Control Documentation and Records

### 11.1 Required Documentation

| Document Type | Purpose | Retention Period | Storage Location | Responsible Person |
|---------------|---------|------------------|------------------|-------------------|
| Control charts | [Purpose] | [Period] | [Location] | [Role] |
| Statistical analysis reports | [Purpose] | [Period] | [Location] | [Role] |
| Process capability studies | [Purpose] | [Period] | [Location] | [Role] |
| Deviation reports | [Purpose] | [Period] | [Location] | [Role] |
| CAPA records | [Purpose] | [Period] | [Location] | [Role] |
| Trend analysis reports | [Purpose] | [Period] | [Location] | [Role] |
| Continuous process verification reports | [Purpose] | [Period] | [Location] | [Role] |

### 11.2 Record Completion Guidelines

- All records must be completed contemporaneously
- Records must be completed in indelible ink (for paper records)
- All data entry fields must be completed
- N/A should be entered when a field is not applicable
- Corrections must be made with a single line through the error, initialed, dated, and reason for change noted
- Electronic records must comply with 21 CFR Part 11 requirements
- All records must be reviewed by a second person before finalization

### 11.3 Electronic Data Management

| System | Data Types | Backup Frequency | Data Integrity Controls | Access Controls | Responsible Person |
|--------|-----------|------------------|-------------------------|----------------|-------------------|
| [System 1] | [Data types] | [Frequency] | [Controls] | [Access levels] | [Role] |
| [System 2] | [Data types] | [Frequency] | [Controls] | [Access levels] | [Role] |

---

## 12. Training Requirements

### 12.1 Required Training

| Role | Training Required | Frequency | Assessment Method | Documentation |
|------|-------------------|-----------|-------------------|---------------|
| Manufacturing operators | [Training topics] | [Frequency] | [Assessment] | [Documentation] |
| Process engineers | [Training topics] | [Frequency] | [Assessment] | [Documentation] |
| Quality assurance | [Training topics] | [Frequency] | [Assessment] | [Documentation] |
| Supervisors | [Training topics] | [Frequency] | [Assessment] | [Documentation] |

### 12.2 Training Topics

- Basic statistical concepts (mean, standard deviation, normal distribution)
- Statistical process control principles
- Control chart interpretation
- Sampling techniques
- Process capability analysis
- Root cause analysis
- Corrective and preventive actions
- Data integrity
- Product-specific process knowledge
- PAT tools and technology (if applicable)
- Alert and action limit responses
- Documentation requirements

---

## 13. References

### 13.1 Internal References

1. Master Manufacturing Formula [Document ID]
2. Product Specification File [Document ID]
3. Process Validation Master Plan [Document ID]
4. Validation Reports [Document IDs]
5. Relevant Standard Operating Procedures:
   - SOP-XXX: Statistical Process Control
   - SOP-XXX: Process Capability Analysis
   - SOP-XXX: Sampling Procedures
   - SOP-XXX: Data Review and Trending
   - SOP-XXX: Deviation Management
   - SOP-XXX: Change Control Management
   - SOP-XXX: Annual Product Review

### 13.2 Regulatory References

1. FDA 21 CFR Part 210 - Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs
2. FDA 21 CFR Part 211 - Current Good Manufacturing Practice for Finished Pharmaceuticals
3. FDA Guidance for Industry - Process Validation: General Principles and Practices
4. EudraLex Volume 4 - EU Guidelines for Good Manufacturing Practice
5. ICH Q8(R2) - Pharmaceutical Development
6. ICH Q9 - Quality Risk Management
7. ICH Q10 - Pharmaceutical Quality System
8. ICH Q11 - Development and Manufacture of Drug Substances
9. ICH Q12 - Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management
10. ASTM E2500 - Standard Guide for Specification, Design, and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment
11. ISPE GAMP 5 Guide: A Risk-Based Approach to Compliant GxP Computerized Systems

---

## Appendices

### Appendix A: Glossary of Terms

- **CPP (Critical Process Parameter)**: A process parameter whose variability has an impact on a critical quality attribute and therefore should be monitored or controlled to ensure the process produces the desired quality.
- **CQA (Critical Quality Attribute)**: A physical, chemical, biological, or microbiological property or characteristic that should be within an appropriate limit, range, or distribution to ensure the desired product quality.
- **Control Chart**: A graphical representation of process data over time, with control limits that indicate the expected range of variation due to common causes.
- **Capability Index (Cp/Cpk)**: Statistical measures of process capability relative to specification limits.
- **PAT (Process Analytical Technology)**: A system for designing, analyzing, and controlling manufacturing through timely measurements of critical quality and performance attributes.
- **RTRT (Real-Time Release Testing)**: The ability to evaluate and ensure the quality of in-process and/or final product based on process data.
- **Special Cause Variation**: Variation that is due to identifiable, assignable causes and is not inherent to the process.
- **Common Cause Variation**: The natural or inherent variation in a process that is due to the system itself.
- [Additional terms as needed]

### Appendix B: Statistical Methods and Formulas

[Include detailed descriptions and formulas for statistical methods used in process control, such as control chart formulas, capability indices calculations, etc.]

### Appendix C: Control Chart Templates

[Include blank control chart templates that can be used for process monitoring]

### Appendix D: Example of Completed Process Control Documentation

[Include examples of properly completed process control documentation to serve as a reference]

### Appendix E: Process Control Implementation Checklist

[Include a checklist that can be used when implementing this process control strategy to ensure all components are addressed]

---

## Approval

| Role | Name | Signature | Date |
|------|------|-----------|------|
| **Author** | | | |
| **Reviewer** | | | |
| **Quality Assurance** | | | |
| **Manufacturing Head** | | | |
| **Site Quality Head** | | | |